Buy, Sell or Hold: OSI Pharmaceuticals Inc. (OSIP-Q)

OSI Pharmaceuticals Inc. (OSIP-Q)

0.00

0.00 (0.00%) 1d

TOP PICK

Has a low market cap. Have a drug that extends life in lung cancer which should be approved around the turn of the year.

Showing 1 to 1 of 1 entries

OSI Pharmaceuticals Inc.(OSIP-Q) Rating

Ranking : 1 out of 5

Bullish - Buy Signals / Votes : 0

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 0

Stockchase rating for OSI Pharmaceuticals Inc. is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

OSI Pharmaceuticals Inc.(OSIP-Q) Frequently Asked Questions

What is OSI Pharmaceuticals Inc. stock symbol?

OSI Pharmaceuticals Inc. is a OTC stock, trading under the symbol OSIP-Q on the (). It is usually referred to as or OSIP-Q

Is OSI Pharmaceuticals Inc. a buy or a sell?

In the last year, there was no coverage of OSI Pharmaceuticals Inc. published on Stockchase.

Is OSI Pharmaceuticals Inc. a good investment or a top pick?

OSI Pharmaceuticals Inc. was recommended as a Top Pick by on . Read the latest stock experts ratings for OSI Pharmaceuticals Inc..

Why is OSI Pharmaceuticals Inc. stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is OSI Pharmaceuticals Inc. worth watching?

In the last year 0 stock analysts on Stockchase covered OSI Pharmaceuticals Inc.. The stock is worth watching.

What is OSI Pharmaceuticals Inc. stock price?

On , OSI Pharmaceuticals Inc. (OSIP-Q) stock closed at a price of $.

Most Recent Experts

Daniel Straus

National Bank Financial

The Panic-Proof Portfolio (Stockchase Research)

Stockchase Premium

The Weekly Buzzing Stocks by Billy Kawasaki

Stockchase

Stan Wong

Private Wealth Management, ScotiaMcleod

Stockchase Insights

5i Research

Stockchase, in its reporting on what has been discussed by individuals on business television programs (in particular Business News Network), neither recommends nor promotes any investment strategies.

We paraphrase the experts by hand, we watch the shows and write down what we understood from the experts’ comments. We are human and can make mistakes, help us fix any errors. If you see something that you know is not right or if there is a problem with the site, feel free to email us at : hello@stockchase.com.